1/47
Vocabulary flashcards covering key pharmacology concepts from the notes.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
The science that studies how drugs interact with living organisms to affect biological functions.
Pharmacology
System for naming drugs that differentiates chemical, generic, and brand (proprietary) names.
Drug nomenclature
Standardized active ingredient name assigned by the International Nonproprietary Name (INN) system for universal use.
Generic name
Commercial or proprietary name given by a manufacturer; trademarked.
Brand name
Chemical name
IUPAC-style name describing the molecular structure of a drug; usually long and not used in practice.
Global, standardized drug name overseen by the WHO for universal identification.
INN (International Non-proprietary Name)
Core pharmacokinetic processes: Absorption, Distribution, Metabolism, Excretion.
ADME
Movement of a drug from its site of administration into the systemic circulation.
Absorption
Dispersion of a drug throughout the body's fluids and tissues after absorption.
Distribution
Biochemical modification of drugs, mainly in the liver, often via CYP enzymes.
Metabolism
Elimination of drugs from the body, primarily through kidneys; also via bile, lungs, etc.
Excretion
Fraction of administered dose that reaches systemic circulation unchanged.
Bioavailability
Liver metabolism of an oral drug before it enters systemic circulation.
First-pass metabolism
An inactive or less active compound that is converted into an active drug in the body.
Prodrug
Pathways to deliver drugs (oral, sublingual, IV, etc.) that affect absorption.
Routes of administration
Affinity for lipids; usually correlates with ability to cross membranes and distribute into fat.
Lipophilicity
Affinity for water; water-soluble; influences distribution and excretion.
Hydrophilicity
Physiological barrier that restricts drug entry into the brain; favors small, lipophilic molecules.
Blood-brain barrier
Family of liver enzymes that metabolize many drugs and influence drug interactions.
CYP450
Initial metabolic reactions (oxidation, reduction, hydrolysis) often by CYP enzymes.
Phase I metabolism
Conjugation reactions increasing water solubility (glucuronidation, sulfation, etc.).
Phase II metabolism
Phase II conjugation adding glucuronic acid to drugs via UDP-glucuronosyltransferases.
Glucuronidation
Phase II conjugation adding sulfate via sulfotransferases.
Sulfation
Phase II conjugation adding an acetyl group via N-acetyltransferases.
Acetylation
Phase II conjugation adding a methyl group via methyltransferases.
Methylation
Phase II reaction attaching glutathione via glutathione S-transferases.
Glutathione conjugation
Theoretical value describing how extensively a drug distributes into body tissues.
Volume of distribution (Vd)
Drugs may bind to plasma proteins; only unbound drug is free to act or be cleared.
Protein binding
Time for the drug concentration in blood to fall by 50%; influences dosing and duration.
Half-life
Drugs with a small margin between therapeutic and toxic doses requiring careful dosing.
Narrow therapeutic index (NTI)
A condition or situation where use of a drug is not advised due to harm risk.
Contraindication
Treatment that must be avoided because risks far outweigh benefits.
Absolute contraindication
Treatment that may be used with caution when benefits outweigh risks.
Relative contraindication
Official prescribing information detailing safe and effective drug use.
Drug insert
A drug that activates a receptor to produce a biological response.
Agonist
A drug that blocks receptor activity, preventing a response.
Antagonist
Activates a receptor but produces a weaker, partial response.
Partial agonist
Reduces receptor activity below its baseline level.
Inverse agonist
Receptor theory
Concept that drugs exert effects by binding to receptors and modulating activity.
Molecule that binds to a receptor (drug, hormone, etc.).
Ligand
A protein that binds ligands to initiate a biological response.
Receptor
The bound form of a receptor and ligand that leads to a cellular response.
Drug-receptor complex
Relationship between drug dose and magnitude of the physiological response.
Dose-response
What the drug does to the body; study of drug effects, receptors, and mechanisms.
Pharmacodynamics
What the body does to the drug; study of ADME processes.
Pharmacokinetics
Measuring drug levels to guide dosing, especially for NTI drugs.
Therapeutic drug monitoring
Physiological changes in older adults that alter drug response and safety.
Age-related pharmacodynamics
Distinct pediatric pharmacodynamics due to immature receptors and enzymes.
Infant pharmacodynamics